Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Corrigendum]
Year: 2021
Type: erratum
Abstract: Figure 8 (A) The scanned densitometry Western blot of viral replication in Huh7 (a) versus -actin (b); lane 1, protein levels of infected untreated cells: lane 2, infected cells treated with curcumin: lane 3, infected cells treated with CsNPs: lane 4, infected cells treated with curcumin chitosan nanocomposite. (B) The scanned densitometry western blot of viral entry (a) versus -actin (b) protein levels in positive; lane 1, untreated infected cells: lane 2, cells treated with curcumin: lane 3, cells treated with CsNPs: lane 4, cells treated with curcumin chitosan nanocomposite: lane 5, cells treated with sofosbuvir. HCV core protein at size of 22 KD.
DOI: 10.2147/ijn.s308439
Authors: Samah A Loutfy, Mostafa H Elberry, Khaled Yehia Farroh, Hossam Taha Mohamed, Aya A Mohamed, ElChaimaa B Mohamed, Ahmed Hassan Ibrahim Faraag, Shaker A Mousa
Language: English
Subfield: Molecular Medicine
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,836
OpenAlex ID: W4242003986